Is ALXO undervalued or overvalued?

As of 2025-03-17, the Intrinsic Value of ALX Oncology Holdings Inc (ALXO) is -12.78 USD. This ALXO valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.83 USD, the upside of ALX Oncology Holdings Inc is -1,640.10%. This means that ALXO is overvalued by 1,640.10%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

	Range	Selected	Upside
a
Fair Value	-12.78 - -12.78	-12.78	-1,640.10%
P/E	(54.82) - (78.45)	(68.78)	-8385.8%
DDM - Stable	(20.46) - (65.58)	(43.02)	-5282.2%
DDM - Multi	(20.89) - (53.92)	(30.33)	-3754.2%